Published in J Exp Med on May 06, 2002
Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol Sci (2009) 2.04
Siglecs and immune regulation. Annu Rev Immunol (2012) 1.81
Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner. J Leukoc Biol (2009) 1.64
B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase. J Exp Med (2008) 1.45
CD22: an inhibitory enigma. Immunology (2007) 1.43
Sialoside analogue arrays for rapid identification of high affinity siglec ligands. J Am Chem Soc (2008) 1.42
Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? Immunology (2010) 1.37
Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc Natl Acad Sci U S A (2004) 1.35
Molecular underpinning of B-cell anergy. Immunol Rev (2010) 1.20
ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling. Mol Cell Biol (2006) 1.14
Bifunctional CD22 ligands use multimeric immunoglobulins as protein scaffolds in assembly of immune complexes on B cells. J Am Chem Soc (2008) 1.09
Siglecs as sensors of self in innate and adaptive immune responses. Ann N Y Acad Sci (2012) 1.08
Regulation of B-cell entry into the cell cycle. Immunol Rev (2008) 1.06
Photocrosslinking of glycoconjugates using metabolically incorporated diazirine-containing sugars. Nat Protoc (2009) 1.05
Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169. PLoS One (2012) 1.04
Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22. Front Immunol (2012) 1.04
The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design. Biochem J (2006) 1.02
B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse. Am J Pathol (2004) 1.02
Dendritic cell-dependent inhibition of B cell proliferation requires CD22. J Immunol (2008) 0.94
CD22 and Siglec-G in B cell function and tolerance. Trends Immunol (2012) 0.93
Click and pick: identification of sialoside analogues for siglec-based cell targeting. Angew Chem Int Ed Engl (2012) 0.92
Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling. EMBO J (2015) 0.89
Models of signal transduction through the B-cell antigen receptor. Immunology (2003) 0.87
Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches. Trends Pharmacol Sci (2015) 0.84
Disubstituted Sialic Acid Ligands Targeting Siglecs CD33 and CD22 Associated with Myeloid Leukaemias and B Cell Lymphomas. Chem Sci (2014) 0.84
Multivalent ligands for siglecs. Methods Enzymol (2010) 0.83
CD22-antagonists with nanomolar potency: the synergistic effect of hydrophobic groups at C-2 and C-9 of sialic acid scaffold. Bioorg Med Chem (2011) 0.82
Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus. PLoS One (2014) 0.79
Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer. Front Oncol (2016) 0.75
Modulation of natural killer cell functions by interactions between 2B4 and CD48 in cis and in trans. Open Biol (2016) 0.75
A Peptide Mimetic of 5-Acetylneuraminic Acid-Galactose Binds with High Avidity to Siglecs and NKG2D. PLoS One (2015) 0.75
Structural characterisation of high affinity Siglec-2 (CD22) ligands in complex with whole Burkitt's lymphoma (BL) Daudi cells by NMR spectroscopy. Sci Rep (2016) 0.75
Photoaffinity probes for studying carbohydrate biology. J Carbohydr Chem (2012) 0.75
The blood-borne sialyltransferase ST6Gal-1 is a negative systemic regulator of granulopoiesis. J Leukoc Biol (2017) 0.75
Hyperresponsive B cells in CD22-deficient mice. Science (1996) 2.86
A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science (1995) 2.68
CD22 is a negative regulator of B-cell receptor signalling. Curr Biol (1997) 2.37
CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity (1996) 2.28
The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell (1991) 2.24
CD22 regulates thymus-independent responses and the lifespan of B cells. Nature (1997) 2.16
Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol (1994) 2.05
Crystal structure of the N-terminal domain of sialoadhesin in complex with 3' sialyllactose at 1.85 A resolution. Mol Cell (1998) 1.86
Siglecs, sialic acids and innate immunity. Trends Immunol (2001) 1.73
CD22 associates with the human surface IgM-B-cell antigen receptor complex. Proc Natl Acad Sci U S A (1993) 1.60
Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc Natl Acad Sci U S A (1998) 1.57
The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes. J Immunol (1993) 1.49
Inhibition of the B cell by CD22: a requirement for Lyn. J Exp Med (1998) 1.48
Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity (1997) 1.36
Association of CD22 with the B cell antigen receptor. Eur J Immunol (1993) 1.35
Functional groups of sialic acids involved in binding to siglecs (sialoadhesins) deduced from interactions with synthetic analogues. Eur J Biochem (1998) 1.29
The oligosaccharide binding specificities of CD22 beta, a sialic acid-specific lectin of B cells. J Biol Chem (1994) 1.26
Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells. J Exp Med (1999) 1.18
Interaction of CD22 with alpha2,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity? Eur J Immunol (2002) 1.13
Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J Exp Med (2002) 1.11
CD22-mediated cell adhesion to cytokine-activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins. J Biol Chem (1995) 1.10
Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22. J Biol Chem (1996) 1.10
Regulation of CD45 engagement by the B-cell receptor CD22. Proc Natl Acad Sci U S A (1995) 1.10
Activation of B lymphocytes: integrating signals from CD19, CD22 and Fc gamma RIIb1. Curr Opin Immunol (1996) 0.99
A novel subset of murine B cells that expresses unmasked forms of CD22 is enriched in the bone marrow: implications for B-cell homing to the bone marrow. Immunology (2000) 0.97
Transcription of the beta-galactoside alpha 2,6-sialyltransferase gene in B lymphocytes is directed by a separate and distinct promoter. Glycobiology (1996) 0.93
Sialic acid analogs and application for preparation of neoglycoconjugates. Methods Enzymol (1994) 0.91
New functions for the sialic acid-binding adhesion molecule CD22, a member of the growing family of Siglecs. Scand J Immunol (2001) 0.84
The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils. Eur J Immunol (2004) 2.38
B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity (2007) 2.28
IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta. J Exp Med (2007) 1.75
Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat Immunol (2007) 1.48
Forced usage of positively charged amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production. J Exp Med (2006) 1.36
Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin. Structure (2003) 1.32
Reduction of marginal zone B cells in CD22-deficient mice. Eur J Immunol (2002) 1.31
CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity. J Immunol (2010) 1.29
Strong and ubiquitous expression of transgenes targeted into the beta-actin locus by Cre/lox cassette replacement. Genesis (2005) 1.25
The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J Immunol (2003) 1.25
Versatile biosynthetic engineering of sialic acid in living cells using synthetic sialic acid analogues. J Biol Chem (2001) 1.22
NFATc1 affects mouse splenic B cell function by controlling the calcineurin--NFAT signaling network. J Exp Med (2011) 1.15
A single DH gene segment creates its own unique CDR-H3 repertoire and is sufficient for B cell development and immune function. J Immunol (2005) 1.13
Regulation of B cell development and B cell signalling by CD22 and its ligands alpha2,6-linked sialic acids. Int Immunol (2006) 1.11
Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Brain (2008) 1.08
Regulation of repertoire development through genetic control of DH reading frame preference. J Immunol (2008) 1.06
Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22. Front Immunol (2012) 1.04
The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design. Biochem J (2006) 1.02
B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB.1/OBF.1-deficient mice. J Exp Med (2003) 1.02
BOB.1/OBF.1 deficiency affects marginal-zone B-cell compartment. Mol Cell Biol (2002) 1.01
Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts. J Immunol (2010) 1.00
Grb2 regulates B-cell maturation, B-cell memory responses and inhibits B-cell Ca2+ signalling. EMBO J (2011) 1.00
Novel mouse mutants with primary cellular immunodeficiencies generated by genome-wide mutagenesis. J Allergy Clin Immunol (2007) 0.98
Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes. Eur J Immunol (2006) 0.96
A modified RMCE-compatible Rosa26 locus for the expression of transgenes from exogenous promoters. PLoS One (2012) 0.95
Differentially regulated expression and function of CD22 in activated B-1 and B-2 lymphocytes. J Immunol (2002) 0.95
B cell-specific deficiency for Smad2 in vivo leads to defects in TGF-beta-directed IgA switching and changes in B cell fate. J Immunol (2006) 0.93
Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling. Int Immunol (2003) 0.93
Crystallographic and in silico analysis of the sialoside-binding characteristics of the Siglec sialoadhesin. J Mol Biol (2006) 0.92
Siglec-G regulates B1 cell survival and selection. J Immunol (2010) 0.91
Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22. Glycobiology (2002) 0.89
B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo. Eur J Immunol (2012) 0.88
CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice. Eur J Immunol (2002) 0.87
Expression of sialyltransferase activity on intact human neutrophils. J Leukoc Biol (2008) 0.87
Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice. J Immunol (2014) 0.87
CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling. Proc Natl Acad Sci U S A (2013) 0.86
Absence of Siglec-H in MCMV infection elevates interferon alpha production but does not enhance viral clearance. PLoS Pathog (2013) 0.85
Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cells. Glycoconj J (2005) 0.85
B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling. Eur J Immunol (2003) 0.85
B cell hyperresponsiveness and expansion of mature follicular B cells but not of marginal zone B cells in NFATc2/c3 double-deficient mice. J Immunol (2005) 0.85
A hypomorphic IgH-chain allele affects development of B-cell subsets and favours receptor editing. EMBO J (2011) 0.84
A critical role for Fc gamma RIIB in the induction of rheumatoid factors. J Immunol (2004) 0.82
Purification and characterization of 9-O-acetylated sialoglycoproteins from leukemic cells and their potential as immunological tool for monitoring childhood acute lymphoblastic leukemia. Glycobiology (2004) 0.82
Human dendritic cells contain cell surface sialyltransferase activity. Immunol Lett (2010) 0.81
Antibody repertoire in a mouse with a simplified D(H) locus: the D-limited mouse. Ann N Y Acad Sci (2003) 0.81
Targeting of CD22-positive B-cell lymphoma cells by synthetic divalent sialic acid analogues. Eur J Immunol (2012) 0.80
Discovery of multifold modified sialosides as human CD22/Siglec-2 ligands with nanomolar activity on B-cells. ACS Chem Biol (2014) 0.80
Gene trap mice reveal an essential function of dual specificity phosphatase Dusp16/MKP-7 in perinatal survival and regulation of Toll-like receptor (TLR)-induced cytokine production. J Biol Chem (2013) 0.79
Functional evaluation of activation-dependent alterations in the sialoglycan composition of T cells. J Biol Chem (2013) 0.79
The role of B cell CD22 expression in Staphylococcus aureus arthritis and sepsis. Microbes Infect (2004) 0.77
The myelin-associated glycoprotein inhibitor BENZ induces outgrowth and survival of rat dorsal root ganglion cell cultures. J Neurosci Res (2007) 0.76
Successful prediction of substrate-binding pocket in SLC17 transporter sialin. J Biol Chem (2012) 0.75
Human CD22 cannot fully substitute murine CD22 functions in vivo, as shown in a new knockin mouse model. Eur J Immunol (2012) 0.75
Erratum: Responsiveness of B cells is regulated by the hinge region of IgD. Nat Immunol (2015) 0.75
Increased red cell turnover in a line of CD22-deficient mice is caused by Gpi1c: a model for hereditary haemolytic anaemia. Eur J Immunol (2012) 0.75